Phibro Animal Health Corporation (PAHC)

Market Cap	508.73M
Revenue (ttm)	982.01M
Net Income (ttm)	14.80M
Shares Out	40.50M
EPS (ttm)	0.37
PE Ratio	33.95
Forward PE	10.09
Dividend	$0.48 (3.82%)
Ex-Dividend Date	Mar 5, 2024

Volume	107,696
Open	13.55
Previous Close	13.61
Day's Range	12.55 - 13.55
52-Week Range	9.40 - 15.96
Beta	0.74
Analysts	Buy
Price Target	18.50 (+47.29%)
Earnings Date	May 8, 2024

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Apr 11, 2014
• Employees: 1,920
• Stock Exchange: NASDAQ
• Ticker Symbol: PAHC

Financial Performance

In 2023, PAHC's revenue was $977.89 million, an increase of 3.78% compared to the previous year's $942.26 million. Earnings were $32.61 million, a decrease of -33.69%.

Analyst Forecast

According to 2 analysts, the average rating for PAHC stock is "Buy." The 12-month stock price forecast is $18.5, which is an increase of 47.29% from the latest price.

Price Target

$18.5

(47.29% upside)

Analyst Consensus: Buy